{"id":251618,"date":"2018-08-08T15:49:04","date_gmt":"2018-08-08T15:49:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=251618"},"modified":"2018-08-08T15:49:04","modified_gmt":"2018-08-08T15:49:04","slug":"cancer-diagnostics-market-2018-to-produce-hefty-cagr-by-top-10-key-players-ready-to-boost-the-industry-revenue-and-demand-till-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cancer-diagnostics-market-2018-to-produce-hefty-cagr-by-top-10-key-players-ready-to-boost-the-industry-revenue-and-demand-till-2023_251618.html","title":{"rendered":"Cancer Diagnostics Market 2018 to Produce Hefty CAGR by Top 10 Key Players | Ready to Boost the Industry Revenue and Demand till 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Cancer Diagnostics Market”<\/div>\n<\/div>\n<\/div>\n
Market Research Future published a research report on \u201cCancer Diagnostics Market \u2013 Forecast Up To 2023\u201d. Report include market Analysis, Scope, Size, Share, Growth, Recent Trends and forecast in detail information. The market is projected to demonstrate a sound growth by 2023, Market will grow at a CAGR of 11.8% during forecasted period. <\/div>\n

Cancer Diagnostics<\/strong> Market Highlights<\/strong><\/p>\n

Cancer is the uncontrolled growth of tumor cells anywhere in the body and can spread to the other parts of body. There are more than 200 different types of cancer such as breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and many more. Several methods, advance technology, have surfaced for diagnosing cancer at an early stage. The continuously rising number of patients suffering with different type of cancer is majorly leading the cancer diagnostics market.<\/p>\n

There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics and many more. Population affected with cancer are showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involve in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.<\/p>\n

Rising demand for better technology, increasing investment in biotechnology and pharmaceutical industries for R&D are driving the market for cancer diagnostics. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology are also expected to fuel the market during the forecast period. However, the high cost of the treatment may slow the market growth during the period 2017-2023.<\/p>\n

The Global Cancer Diagnostics Market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023.<\/p>\n

Get Sample PDF Illustration @ <\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/1962<\/a><\/p>\n

Segments for Global Cancer Diagnostics Market<\/strong><\/p>\n

The global cancer diagnostics market is segmented on the basis of types, application, and end user. On the basis of the type, it is segmented into biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics, and others. On the basis of the application, it is segmented into lung cancer, breast cancer, colorectal cancer, cervical cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, liver cancer, pancreatic cancer, and others. On the basis of the end user, it is segmented into diagnostic center, clinic, hospital, research institutes, and others.<\/p>\n

Key Players for Global Cancer Diagnostics Market<\/strong><\/p>\n

Some of key the players in the market are Armune BioScience, Inc. (U.S.), Arquer Diagnostics Ltd (U.K), BioMark Diagnostics Inc. (Canada), Biotheranostics, Inc. (U.S.), Cancer Diagnostics, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K), C.R. Bard, Inc. (U.S.).<\/p>\n

Regional Analysis for Global Cancer Diagnostics Market<\/strong><\/p>\n

The Americas dominate the Global Cancer Diagnostics Market<\/a><\/strong> owing to the presence of huge patient population with cancer, high healthcare spending, and increasing government support for research & development. According to a report published by the breast cancer information and awareness, in 2017, around 252,710 new cases of invasive breast cancer are expected to be diagnosed in women, along with 63,410 new cases of non-invasive breast cancer.<\/p>\n

Europe holds the second largest share of the global cancer diagnostics market as result of increasing focus of various government agencies on the treatment of diseases. Moreover, the growing public awareness is also likely to boost the European market.<\/p>\n

Asia Pacific is the fastest growing market across the globe. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government initiatives for research & development are projected to drive the market in China and India.<\/p>\n

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.<\/p>\n

Brief Table of Contents of Report<\/strong><\/p>\n

Chapter 1. Report Prologue<\/p>\n

Chapter 2. Market Introduction<\/p>\n

Chapter 3. Research Methodology<\/p>\n

Chapter 4. Market Dynamics<\/p>\n

Chapter 5. Market Factor Analysis<\/p>\n

Chapter 6. Global Cancer Diagnostics Market, By Type<\/p>\n

Chapter 7. Global Cancer Diagnostics Market, By Application<\/p>\n

Chapter 8. Global Cancer Diagnostics Market, By End User<\/p>\n

Chapter 9. Global Cancer Diagnostics Market, By Region<\/p>\n

Chapter 10. Competitive Landscape<\/p>\n

Chapter 11. Company Profile<\/p>\n

Chapter 12. Conclusion<\/p>\n

Chapter 13. Appendix<\/p>\n

Get Prime Discount on Report @ <\/em><\/strong>https:\/\/www.marketresearchfuture.com\/check-discount\/1962<\/a><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/cancer-diagnostics-market-1962<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Cancer Diagnostics Market” Market Research Future published a research report on \u201cCancer Diagnostics Market \u2013 Forecast Up To 2023\u201d. Report include market Analysis, Scope, Size, Share, Growth, Recent Trends and forecast in detail information. The market is projected to demonstrate … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-251618","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/251618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=251618"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/251618\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=251618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=251618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=251618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}